Coronary Calcium in the ED low-intermediate risk ED population have predominantly shown high sensitivity (97% to 100%) and negative predictive value (93% to 100%) with modest specificity in the range of 54% to 63%. [4] [5] [6] [7] Although these test characteristics would suggest the use of CAC score for ED triage of acute chest pain, CAC score as a stand-alone test for ED chest pain triage has not been recommended per current appropriate use criteria. 8 Notable reasons for this recommendation are that evidence for benefit of CAC score was derived from relatively small cohort studies, the possibility of missing obstructive noncalcified plaque, and the rapidly emerging evidence base that CCTA is a safe, efficient tool in the ED for triage of low-intermediate risk acute chest pain (ACP). [1] [2] [3] 9 In practice, the use of the CAC scan in the ED setting has evolved to become an adjunct to CCTA serving 2 primary functions. First, the CAC scan can be used as a gatekeeper to CCTA. A high calcium score could not only negatively affect the interpretability of CCTA 10 but would also increase the likelihood of having obstructive CAD. 11 Accordingly, some institutions may abort CCTA at a prespecified CAC score threshold ranging from 400 to 1000. However, there is scant evidence to validate such an approach. Second, the CAC scan has been used to define the smallest scan length of the CCTA scan to minimize radiation exposure. 12 However, in the era of dual source CT and prospective ECG triggering, which offer substantial reduction in radiation dose, the advantage of such a CAC scan-guided approach is less clear.
In this prespecified analysis of the Rule Out Myocardial Infarction using Computer-Assisted Tomography (ROMICAT) II trial, we sought to assess the use of a CAC scan before CCTA with respect to its diagnostic accuracy to exclude ACS, interpretability of CCTA, and radiation exposure. In an exploratory analysis, we also evaluate the diagnostic accuracy of selective CCTA strategies for diagnosing ACS, whereby CAC scan is performed initially, followed by selective use of CCTA.
Methods

Study Population
We performed a subanalysis of patients in the ROMICAT II trial who underwent both CAC scanning and CCTA. The ROMICAT II trial was a multicentered randomized controlled clinical trial consisting of 1000 patients at 9 US centers who presented to the ED during weekday daytime hours with symptoms suggestive of ACS, but without ischemic ECG changes or elevated initial cardiac biomarker. The study design and primary results have been previously reported. 1, 13 Briefly, eligible patients were between the ages of 40 and 74 years with chest pain or anginal equivalent of ≥5 minutes duration within 24 hours of ED presentation, were in sinus rhythm, and warranted further risk stratification to rule out ACS. Major exclusion criteria were history of known CAD, new diagnostic ischemic changes on the initial ECG, initial troponin in excess of the 99th percentile of the local assay, impaired renal function (creatinine >1.5 mg/dL), hemodynamic or clinical instability, known allergy to iodinated contrast agent, body mass index >40 kg/m 2 , or currently symptomatic asthma. All patients were randomized to either CCTA as part of the initial evaluation or to the standard ED evaluation strategy, as dictated by local caregivers. Patients discharged within 24 hours of ED presentation were contacted by phone within 72 hours to evaluate for potential missed ACS. Patients were also evaluated 28 days after discharge from the ED or hospital by phone interview and queried about repeat ED visits or hospitalizations for recurrent chest pain, diagnostic testing/ interventions, and major adverse cardiac events, with verification by medical records. The study was approved by the institutional review board at each participating site and all participants provided informed consent. In this secondary analysis, we included the 473 patients who underwent both CAC and CCTA, which represents 94% of the 501 subjects that were randomized to the CCTA arm.
CAC and CCTA Protocol
As part of the protocol, all patients undergoing CCTA had a CAC scan that was not used to guide the decision-making process. The results of the CCTA were used to triage patients under the discretion of the ED physician. CAC scanning and CCTA were performed with 64-slice or higher CT technology. Specific CT scanner types used among the sites included GE 64-Slice Lightspeed, GE Lightspeed VCT, Siemens 64-Slice Sensation, Siemens Dual Source 64-Slice Definition, Siemens Dual Source 128-Slice Flash, and Philips Brilliance 256-Slice iCT. For the CAC scan, a standard noncontrast prospective scan was performed. CAC scores were calculated using the Agatston method and expressed in Hounsfield units. 14 For CCTA, either retrospective or prospectively gated acquisitions were allowed.
End Points
The primary end point was ACS, defined as unstable angina and myocardial infarction during the index hospitalization. The safety end point, major cardiovascular events, was defined as death, myocardial infarction, unstable angina, or urgent coronary revascularization that occurred within 28 days. Both ACS and major cardiovascular events were adjudicated by an external, independent Clinical Events Committee. CAC score was dichotomized by 0 and its optimal cut point for ACS of 22. CCTA findings were categorized into no CAD, nonobstructive CAD, and obstructive CAD. Obstructive CAD was defined in 2 ways, such as (1) 50% stenosis threshold using a binary cut point of 50% luminal stenosis in any epicardial vessel, and (2) 70% stenosis threshold using ≥50% luminal diameter stenosis for left main, or ≥70% stenosis for other major epicardial vessels as interpreted at the site level by Level III CT readers, who also determined the interpretability of the CCTA scans. We defined 4 selective CCTA strategies using the 50% and 70% stenosis thresholds. For these selective CCTA strategies, an initial use of CAC score was evaluated and if CAC score was negative (by cut points of 0 or 22), then CCTA would not be required; and if CAC score was positive, then selective CCTA findings would be used using either 50% or 70% stenosis thresholds. Radiation exposure from testing was calculated in mSv for CAC scan and CCTA, using standard methods, including a conversion coefficient of 0.014 for the chest for CCTA scans. 15
Statistical Analysis
Descriptive statistics were expressed as mean±SD and median with 25th and 75th percentile for continuous variables and as frequency and percentages for categorical variables. To test the association between categorical variables and our ordinal outcome of CAC score, we used the Mantel-Haenszel statistic with row mean rank scores or linear trend, as appropriate. To measure statistical correlation between continuous variables and strata of CAC scores, we used the Spearman rank correlation coefficient. We determined the optimal cut point for ACS detection of CAC score to be 22 using the greatest average of the sensitivity and specificity. To determine the diagnostic accuracy of the various strategies for the diagnosis of ACS (CAC>0, optimal CAC cut point ≥22, CCTA and selective CCTA using 50% and 70% stenosis thresholds with both CAC cut points), we calculated the sensitivity, specificity, positive predictive value, negative predictive value, and accuracy and computed the 95% binomial proportion confidence interval. We used McNemar test to compare sensitivity and specificity between strategies. Logistic regression was used to determine the c-statistic, which is equivalent to the area under the receiver operator characteristic curve to assess the discriminatory capacity of the various CAC, CCTA, and combinations of CAC score with CCTA strategies. C-statistics were compared using the ROC contrast test method of DeLong et al. 16 To assess for incremental value of CAC score when combined with CCTA, we performed a Likelihood ratio test. For comparison of CCTA and invasive coronary angiography (ICA) for stenosis, we used Cohen κ statistics with McNemar χ 2 test to determine the degree of agreement between the 2 modalities and report exact agreement by varying levels of CAC scores. All analyses were performed using SAS (version 9.2, Cary, NC). For all analyses, a 2-tailed P<0.05 denoted significance.
Results
Study Population
Baseline characteristics of the 473 patients and as stratified by range of calcium score are summarized in Table 1 . The ACS rate was 8% (n=38), identical to that in the overall trial. Patients with higher calcium scores were older, more likely to be men, and had more traditional risk factors. There were 253 (53%) patients with no coronary calcium (CAC=0), whereas 19 (7%) had CAC scores >400.
CAC of Zero and ACS
Patients with lower CAC scores were less likely to have a discharge diagnosis of ACS. Among 253 patients with CAC=0, there were 2 patients with ACS (0.8%; 95% confidence interval, 0.1-2.8%). One patient had unstable angina because of noncalcified severe stenosis in the left circumflex artery and the second patient had an anomalous right coronary artery arising from the main pulmonary artery, resulting in a non-ST-segment-elevation myocardial infarction, where the myocardial ischemia is a resultant of flow reversal via collateral and perfusion of the right coronary artery territory by relatively oxygen depleted blood and lower perfusion pressures. 17 (Figures I and II in the Data Supplement).
Performance of Various CT Strategies for ACS
The sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy, and c-statistic of CAC and the various CCTA strategies for determination of ACS are shown in Table 2 . The optimal cut point of CAC for ACS detection was 22 (c-statistic, 0.81), with 318 patients (67%) having CAC <22. High sensitivity was observed with all CT strategies and not different when compared among strategies (all P=nonsignificant). Specificity increased markedly from 58% with CAC>0 to 89%-96% when using CCTA or selective CCTA strategies (all P<0.001). Although specificity improved from 89% with the 50% CCTA threshold to 92% with optimal CAC-selective CCTA strategy (P=0.002), there were no differences between the other sensitivities or specificities when using either CCTA or selective CCTA strategies with 50% or 70% stenosis thresholds (all P=NS).
The figure shows the area under the curve and corresponding c-statistic of CAC>0 (0.76), continuous CAC (0.86), and CCTA (0.92) for predicting ACS. CAC was inferior to CCTA for predicting ACS (c-statistic, 0.86 versus 0.92; P=0.03). Combining CAC score with CCTA did not improve the detection of ACS (CAC+CCTA c-statistic 0.93 versus CCTA c-statistic 0.92; P=0.88). ACS indicates acute coronary syndrome; CAC, coronary artery calcium; CI, confidence interval; CCTA, cardiac computed tomographic angiography; CT, computed tomography; NPV, negative predictive value; and PPV, positive predictive value. For Selective CCTA strategy, selective CCTA is performed after an initial CAC>0, as well as with optimal cut point CAC≥22.
Figure.
Receiver operating characteristic curve for prediction of acute coronary syndrome by coronary artery calcium (CAC)>0, continuous CAC score, cardiac computed tomographic angiography (CCTA), and combined CCTA and CAC score. Obstructive coronary artery disease on CCTA was defined using the 70% stenosis threshold. AUC indicates area under the curve.
The c-statistics were similar between using CCTA alone versus a selective CCTA strategies with either 50% or 70% stenosis threshold, irrespective of using the CAC cut point of 0 or the optimal CAC cut point of 22 (both P≥0.09).
CCTA Findings and Study End Points in Patients With High CAC Scores
As shown in Table 3 , across high strata of CAC score, the majority (64% to 86%) were identified as having obstructive CAD by CCTA, with 39% to 49% deemed to have ACS. About three fourth of patients with high CAC scores were admitted to the hospital with <18% being directly discharged from the ED. Subsequent noninvasive diagnostic testing was performed with nuclear imaging in 1 of 5 patients, with no patients undergoing subsequent exercise treadmill test or stress echocardiography. About one half of the patients with high CAC score underwent ICA, and one third requiring revascularization. Notably, although the proportion of interpretable CCTA studies decreased with increasing CAC score, the majority were deemed interpretable even among the highest CAC cut points (73% for CAC >1000).
Agreement of CCTA and ICA by CAC Score
In 51 patients who underwent ICA, there was moderate agreement between CCTA and ICA when using a stenosis threshold of 50% (κ, 0.44; P=0.01) or 70% (κ, 0.42; P=0.12). Table 4 depicts the agreement between CCTA and ICA in all patients with CAC scores and ICA, as well as stratified by high CAC score. The exact agreements were good but not perfect between CCTA and ICA, irrespective of CAC score. Table 5 shows the mean effective radiation dose of CAC scan and CCTA by CT scanner type. Overall, the mean effective radiation dose from the CAC scan was an additional 1.4 mSv. With newer 128-dual source CT scanner technology, the mean effective radiation dose of CAC scan was 0.5 mSv. It is notable that the mean effective radiation dose of a CAC scan is 14% of that for CCTA; for the prospective ECG-triggered CCTA, the CAC scan represents 23% of the radiation dose of CCTA. 
Radiation Dose From CAC Scan
Discussion
The main finding of this study is that CAC score does not provide incremental value beyond CCTA in ruling out ACS in low-intermediate risk patients presenting to the ED with ACP. In fact, CAC score alone would have missed 2 patients with ACS in our cohort whose CAC scores were 0. However, higher CAC score was associated with an increased number of nondiagnostic examinations even though the majority (73%) with CAC score >1000, were diagnostic. CAC scan resulted in 1.4 mSv of radiation exposure, which was 14% of the dose associated with CCTA alone.
Our findings that a CAC scan alone offers inferior diagnostic accuracy and no incremental diagnostic value to CCTA for ACS prediction are both consistent with the fact that a CAC scan does not provide the direct visualization of a culprit coronary plaque. As many studies have shown, the development of coronary calcification occurs late in the atherosclerotic process, and does not necessarily identify the location of a vulnerable plaque that represents the culprit lesion in ACS. 18 Vulnerable plaques typically are not heavily calcified and instead have been described as having lipid-rich cores separated from the vessel lumen by a thin fibrous cap. 19, 20 However, CAC scans do afford some advantages, including its potential to tailor the subsequent CCTA protocol because the fraction of nondiagnostic examinations and the fraction with obstructive CAD increased with higher calcium score. For example, given that 80% of subjects with a CAC score >400 have obstructive CAD, the temporal acquisition window can be widened during which the maximum tube current is applied to provide additional phases to be reconstructed during postprocessing for image interpretation to evaluate for coronary stenosis. In addition, the CAC scan can optimize the scan length of the CCTA to potentially reduce overall radiation exposure. 21 However, this potential advantage may ultimately be supplanted by many recent technological advances (independent of reducing scan length) that have been validated to decrease effective radiation dose of CCTA, including high-pitch helical prospective ECG-triggered scanning. [22] [23] [24] In keeping with the as low as reasonably achievable principle, some centers have newer CT scanners and software algorithms, where sub-mSv CCTA scans are already performed. [25] [26] [27] Another benefit of CAC scans is that they do not require use of iodinated contrast. Similar to such improvements in radiation dose, modern CCTA protocols have resulted in significant reductions in potentially nephrogenic contrast dose, thus the risk of contrast-induced nephropathy is low, particularly in patients with preserved renal function. 28, 29 However, the issue of contrast-induced nephropathy is valid, and patients with renal impairment should not undergo CCTA as there are other alternative noninvasive stress testing available (exercise treadmill test, stress echocardiography, and stress nuclear).
Moreover, the role of the CAC scan in the ED chest pain evaluation extends beyond its ability to predict near-term ACS. Numerous studies have established the longer-term prognostic value of calcium scoring in intermediate risk asymptomatic individuals. [30] [31] [32] [33] Although these studies may not be applicable to our entire symptomatic cohort, most of the subjects in our cohort did not develop ACS, but in those with coronary atherosclerosis, the calcium score may arguably still provide an objective, quantitative measure of future cardiovascular risk.
With respect to using selective CCTA, although an argument can be made for performing selective CCTA after the CAC scan (for those with CAC>0 or optimal CAC cut point ≥22) given similar overall test characteristics for detection of ACS, we will still miss few patients who develop ACS with negative CAC score with either 0 or 22. Furthermore, using a selective CCTA strategy, patients with negative CAC score would not undergo CCTA and may have unrecognized severity of noncalcified plaque that would be appropriate for risk factor modification or preventive medical therapy, particularly in those who has CAC score >0 but <22. 34 In addition, alternative causes of ACP, such as dangerous incidental findings of aortic dissection and pulmonary embolism even if not protocoled as a triple rule out scan, 35 would not be detected on a noncontrast CT scan alone and would be missed in a patient with negative CAC if a selective CCTA strategy was used. Finally, selective CCTA in a real-world scenario may be less than ideal and hampered by workflow issues, such as need for immediate CT interpretation at the scanner in a busy ED CT scanner where noncardiac imaging, such as strokes and trauma evaluations takes priority over low-intermediate risk ACP patients awaiting triage decision.
Limitations
The lack of follow-up beyond 28 days limits the ability to evaluate longer-term advantages of CAC scores for event prediction. However, there is evidence that CAC score provides useful prognostic information for both patients with and without chest pain. Despite 253 patients with CAC score of zero, we were not powered to detect a missed ACS rate of <1%. Thus, while the missed ACS rate may be <1%, it can be as high as 2.8%. Even in our small cohort of 253 patients with CAC=0, we provide 2 examples in our study where the CCTA findings did indeed change the triage decision and influenced the overall care and management of the patients.
Conclusions
In ED patients with ACP, CAC score of zero does not exclude ACS, and CCTA is a superior test for the diagnosis of ACS. There were no incremental benefit of combining CAC score and CCTA nor were there differences with selective CCTA strategies over CCTA alone. The majority of CCTA scans with high CAC scores were interpretable. Thus, in patients with ACP patients, CAC results should not influence the decision to proceed with CCTA, and its use for tailoring the subsequent CCTA scan and longer-term prognostic value should be balanced with the additional radiation exposure required.
